CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
7,781,226
Share change
-317,453
Total reported value
$14,081,000
Price per share
$1.81
Number of holders
23
Value change
-$431,455
Number of buys
11
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q1 2018

As of 31 Mar 2018, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,781,226 shares. The largest 10 holders included SV Health Investors, LLC, Clarus Ventures, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DEUTSCHE BANK AG\, OPPENHEIMER & CO INC, DIMENSIONAL FUND ADVISORS LP, JACOBS LEVY EQUITY MANAGEMENT, INC, Alyeska Investment Group, L.P., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.